Arsenal received a significant boost as star winger Bukayo Saka resumed full training, putting him in contention for next Tuesday’s Premier League clash against Fulham. The 23-year-old England international has been recovering from a hamstring tear sustained during Arsenal’s December victory at Crystal Palace, which required surgical intervention.
Medical staff have closely monitored Saka’s rehabilitation process, with his recovery reportedly progressing as expected. While the club remains cautious about rushing his return, sources indicate the dynamic attacker could feature in Mikel Arteta’s matchday squad for the Craven Cottage encounter if he suffers no setbacks in coming days.
Saka’s potential return comes at a crucial juncture for the title-chasing Gunners, with their Champions League quarterfinal against Real Madrid looming in April. Club doctors will conduct final fitness assessments before clearing the academy product for competitive action, but his participation in full training sessions suggests he could soon resume his influential role in Arsenal’s attack.
ADBN Sports understands Arsenal’s medical team will make a final decision on Monday after evaluating Saka’s response to intensive training drills this weekend. His availability would provide timely reinforcement as Arteta’s squad navigates a demanding schedule across multiple competitions.
Injury Comeback Timeline:
✓ December 2023: Suffered hamstring tear at Selhurst Park
✓ January 2024: Underwent successful surgery
✓ February-March: Gradual rehabilitation program
✓ March 26: Returned to full first-team training
✓ April 2: Potential return vs Fulham (PL)
✓ April 9/10: Expected availability vs Real Madrid (UCL)
The winger’s return could prove pivotal for Arsenal’s Premier League title push and European ambitions, with his 8 goals and 12 assists this season highlighting his importance before the injury. Club officials emphasize they won’t risk aggravating the condition, but Saka’s presence in training has lifted squad morale ahead of the season’s decisive phase.
